 
 
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: ASO-10-27 | BIIB-058 | BIIB058 | Ionis-SMNrx | ISIS 396443 | ISIS SMNRx | ISIS-SMNRx | ISIS396443 | Spinraza®
                                 nusinersen is an approved drug (FDA (2016), EMA (2017)) Compound class: 
                                                            Nucleic acid
                                 
                                    
                                        Comment: Nusinersen (ISIS 396443) is an antisense oligo(ribo)nucleotide (ASO) which induces survival motor neuron (SMN) protein expression from SMN2 genes with the exon 7-skipping mutation [7]. Nusinersen was initially available for use as a designated orphan drug (by the US FDA and EMA), and was the first drug to be fully approved for the treatment of spinal muscular atrophy (SMA). The sequence contains 2'-O-(2-methoxyethyl) (2'-MOE)-oligoribonucleotides to reduce nuclease degradation and enhance binding affinity towards the complementary RNA. The full sequence is [2'-O-(2-methoxyethyl)](3'-5')(P-thio)(mU-mC-A-mC-mU-mU-mU-mC-A-mU-A-A-mU-G-mC-mU-G-G) as detailed in the INN record for the agent. The sequence for nusinersen is claimed in patent WO2010148249A1 as SEQ ID NO: 1 [1]. | 
 | |||||||||||||||
| Nucleic Acid Sequence  | |
| TCACCTTTATAATGCTGG | |
| Download 2D Structure  | |
| Canonical SMILES | Download | 
| Isomeric SMILES | Download | 
Molecular structure representations generated using Open Babel